Mónica Condinho

Prof. Mónica Condinho

Faculty of Sciences and Technology, University of Algarve, Faro, Portugal
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Pharmacy
Verified
Journal Article
Open access
PDF file
Mónica CondinhoMónica Condinho
Mónica Condinho
IRIsabel Ramalhinho
Isabel Ramalhinho
CSCarlos Sinogas
Carlos Sinogas
The objectives of this study are to report the contribution of pharmacists to smoking cessation and study the determinants of smoking cessation success in eight pharmacies in Portugal (south) between 2009 and 2019. A real-life study was conducted with a sample of smokers who participated in pharmacist consultations. The sample included 135 smokers (average age of 47.9 ± 1.21 years), 79 (58.5%) of whom were male. In parallel with the motivation and behavioral approach, 116 (85.9%) smokers received pharmacological therapies: 108 (80.0%) were treated with nicotine replacement products and eight (5.9%) with non-nicotine medications. The interventions resulted in 70 (51.9%) smokers complying with the quit day, of whom 59 (43.7%) were smoking-abstinent at the end of the first month. Success rates were reduced to 32.6%, 28.1%, and 20.7% at the end of the 3rd, 6th, and 12th months, respectively. Smoking cessation was more successful for the participants receiving pharmacological therapies (Fisher’s exact test, p < 0.001) and those who participated in more pharmacist consultations (χ2 = 59.994, p < 0.001) and more telephone sessions (χ2 = 17.845, p < 0.001). Pharmacists can contribute significantly to the promotion of smoking cessation. Smokers who are more thoroughly followed up by pharmacists showed increased success rates when compared with smokers having fewer sessions with pharmacists.

28 July 2015 in Vitae
Verified
Journal Article
Open access
PDF file
Mónica CondinhoMónica Condinho
Mónica Condinho
FFFernando Fernandez-Llimos
Fernando Fernandez-Llimos
Isabel V. FigueiredoIsabel V. Figueiredo
Isabel V. Figueiredo
CSCarlos Sinogas
Carlos Sinogas
Antecedentes: Según la Organización Mundial de la Salud, el tabaco es una de las mayores amenazas del mundo, siendo urgente promover el abandono tabáquico. La efectividad de las intervenciones farmacéuticas en cesación tabáquica ha sido documentada en la literatura, pero no en Portugal. Objetivo: Comunicar los resultados preliminares de un estudio para evaluar la efectividad de un programa de cesación tabáquica desarrollado en farmacias comunitarias portuguesas usando un régimen de out-sourcing. Métodos: En el ámbito de un programa de atención farmacéutica implantado en siete farmacias por un farmacéutico externalizado, se desarrolló una consulta de cesación tabáquica siguiendo las recomendaciones e instrumentos de la Dirección General de Salud de Portugal. Se identificó a los fumadores y el personal de la farmacia durante sus actividades rutinarias les invitó a unirse al programa. Los que aceptaban firmaban un consentimiento informado. Mediante consultas presenciales y telefónicas y a través de un abordaje global del paciente, se definieron en acuerdo con el paciente planes personalizados de abandono del tabaquismo. La efectividad del servicio se midió mediante las tasas de cesación a 1, 6 y 12 meses. Las variables continuas se expresaron como media ± error estándar de la media. Resultados: Durante aproximadamente 5 años (entre enero 2009 y julio 2014), 69 fumadores se unieron al programa. De estos, 17 desistieron durante la primera consulta. Entre los restantes 52 pacientes, tenían 47.4 ± 2.11 años y el 55,8% eran hombres. Se realizaron 264 consultas farmacéuticas y, en media cada paciente recibió 7.7 ± 0.81 intervenciones. La mayoría de las intervenciones (60,1%) eran farmacológicas (p.e. productos de substitución de nicotina), y el restante 39,9% fueron medidas no farmacológicas (p.e. entrevista motivacional). Cinco pacientes fueron remitidos al médico. Después de 1 mes de la fecha convenida para el inicio de la cesación, 37 pacientes (53,6%) estaban en abstinencia; 6 meses más tarde el número se reducía a 24 (34,8%) y un año más tarde 16 pacientes (23,2%) permanecían abstinentes.Conclusión: La implantación de un programa de casación tabáquica en farmacias comunitarias, utilizando un farmacéutico externo, puede contribuir efectivamente a la cesación tabáquica en Portugal.

7 June 2024 in Pharmacy
Verified
Journal Article
Open access
PDF file
Mónica CondinhoMónica Condinho
Mónica Condinho
IRIsabel Ramalhinho
Isabel Ramalhinho
CVCatarina Vaz-Velho
Catarina Vaz-Velho
CSCarlos Sinogas
Carlos Sinogas
Portugal has a high prevalence of anxiety and depression, and community pharmacists are well-placed to identify mental health problems and monitor their treatment. This study aimed to screen undiagnosed people for symptoms of anxiety and depression and to monitor these conditions in diagnosed patients. We conducted an observational, cross-sectional study of a sample of community pharmacy users. Anxiety and depression symptoms were assessed using the Generalised Anxiety Disorder-7 (GAD-7) and Patient Health Questionnaire-9 (PHQ-9). Altogether, 591 participants were enrolled between September 2020 and July 2021, 74.9% of whom were female. Of the 477 undiagnosed participants who completed the GAD-7, 87 (18.2%) had moderate or severe anxiety symptoms. Of the 485 participants who completed the PHQ-9, 59 (12.1%) had moderate or severe symptoms of depression. Of the 94 patients diagnosed with anxiety, 37 (39.4%) reported moderate to severe symptoms. Similarly, of the 97 patients with depression, almost half (49.5%) reported moderate to severe symptoms. Anxiety levels were lower among men and among those who reported not taking any medication (p < 0.001). Moderate or severe symptoms of depression were more common among women (p < 0.001), participants with lower education levels (p < 0.005), participants who live alone (p < 0.007), and those taking medication for insomnia (p < 0.001), pain (p < 0.001), anxiety (p < 0.001), and/or depression (p < 0.001). Screening for anxiety and depression revealed that a significant proportion of undiagnosed participants had clinically relevant symptoms of anxiety and depression. However, among participants diagnosed with anxiety and depression, between 40% and 50% were uncontrolled, respectively. These data highlight pharmacists’ role in identifying customers at risk of anxiety and depression as well as the need for better monitoring of those already diagnosed.

26 January 2026 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
MAMaria Patricia Pereira Almeida
Maria Patricia Pereira Almeida
Mónica CondinhoMónica Condinho
Mónica Condinho
Colorectal cancer is among the most prevalent and lethal malignancies worldwide. Its initially asymptomatic nature contributes to a high incidence of metastatic cases. Although predominantly diagnosed in older adults, the incidence among younger populations is rising at an alarming rate. Historically, treatment has relied on antineoplastic agents such as 5-fluorouracil, irinotecan, and oxaliplatin. While these agents remain in use, their effectiveness is limited, particularly in metastatic disease, with modest improvements in overall survival and progressionfree survival. Moreover, their low target specificity results in significant systemic toxicity. This underscores the urgent need formore selective and less toxic therapeutic strategies, such as monoclonal antibodies. Monoclonal antibodies targeting Vascular Endothelial Growth Factor (VEGF), Epidermal Growth Factor Receptor (EGFR), and immune checkpoints have become integral to the management of metastatic colorectal cancer. Notable examples include bevacizumab (anti-VEGF), cetuximab and panitumumab (anti-EGFR), and the immune checkpoint inhibitors pembrolizumab, nivolumab, and ipilimumab. Their clinical success especially when guided by molecular tumour profiling highlights their contribution to improved patient outcomes. In addition, other targeted therapies distinct from monoclonal antibodies are currently under investigation.

15 September 2018 in European Respiratory Journal
Verified
Conference Paper
Closed access
SRSofia Belo Ravara
Sofia Belo Ravara
VAVera Afreixo
Vera Afreixo
CACarlos Manuel de Sousa Albuquerque Albuquerque
Carlos Manuel de Sousa Albuquerque Albuquerque
Mónica CondinhoMónica Condinho
Mónica Condinho
MRMarília Santos Rua
Marília Santos Rua
Jorge BonitoJorge Bonito
Jorge Bonito
Aim: To explore attitudes/knowledge, perceptions of curricula contents and confidence/competence to intervene in tobacco cessation/prevention among finalists medical students in Portugal. Methods: In 2016, a national cross-sectional study was carried out using a multiple-dimension questionnaire administered online/classroom. Results: Participants: 452 (24.2% of finalists), 72.1% females, age mode 23 years. Cronbach’s alfa analysis was reliable. While most students reported good knowledge about tobacco hazards, positive attitudes regarding their role in supporting cessation and their need for training; a significant part disagreed that they should be role models and that their behaviour would influence cessation outcomes; denying that curricula impacts in their attitudes. While most students reported receiving good theoretical training, particularly in tobacco hazards, a significant part considered their training poor, respectively in behaviour change and brief cessation skills: 38.4% reported low self-competence to intervene. From a 1-10 scale, mean score of self-confidence to intervene in cessation was 5.5. This was significantly associated with tobacco behaviour, SHS exposure, attitudes/knowledge, perception of theoretical training, and, above all, clinical skills training and tobacco curricula extension (mean:3 hours). Students considered their training insufficient and provided clear indications about curricula gaps (contents/format). Conclusions: There is room for improving undergraduate medical education in tobacco control, including the hidden curriculum. A national-wide assessment involving students is a key step to engage decision makers and stress the need for curriculum and organizational change.

15 September 2018 in European Respiratory Journal
Verified
Conference Paper
Closed access
SRSofia Belo Ravara
Sofia Belo Ravara
VAVera Afreixo
Vera Afreixo
Mónica CondinhoMónica Condinho
Mónica Condinho
MRMarília Santos Rua
Marília Santos Rua
CACarlos Manuel de Sousa Albuquerque Albuquerque
Carlos Manuel de Sousa Albuquerque Albuquerque
Jorge BonitoJorge Bonito
Jorge Bonito
Aim: To assess tobacco and e-cigarette (EC) use, and exposure to SHS among pharmaceutical (PHs), nursing (Ns), medical (MDs), and medical dental (Ds) finalists students. Methods: In 2016, a national cross-sectional questionnaire-based study involved health science schools in Portugal (46.6% online). A descriptive/inferential and regression analysis was performed. Results: Participants: 2095 students, 79.5% females, mode age 23 years, 34.5% collaboration rate. Of the finalists, more than half had experimented tobacco (in descending order: box cigarettes, RYO, shisha, cigarillos, cigars, p<0.001). Experimentation of EC ranged from 9.3% (MD) to 13.4% (Ns). EC occasional consumption was more frequent than daily. Prevalence of tobacco use was: Ns-22.1% (23.5% in males; 21.8% in females, p=0.6); Ds-19.7% (29.7% in males; 15.9% in females, p=0,018); PHs19.4% (32.3% in males, 15.1% in females; p=0,003); MDs12,2%, (17.1% in males; 10.2% in females, p=0,049), p<0.001. Among all courses, regular smoking overlaps with college admission; most smokers reported low dependence and desire to quit, while 20% reported readiness to quit; motivation to quit was not triggered by being a role model; Nursing students reported significantly higher dual consumption and experimentation of multiple tobacco products, p<0.001. Being female or an MD predicted not using tobacco. Exposure to SHS was rather common in leisure spaces and did not significantly varied among courses. Conclusions: Tobacco use, experimentation of e-cigarette, and exposure to SHS are common among health science students, highlighting the need to implement comprehensive tobacco control policies in health science schools.